REVIEW 2 cited by
Pretrained ViTs Yield Versatile Representations For Medical Images
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Convolutional Neural Networks (CNNs) have reigned for a decade as the de facto approach to automated medical image diagnosis, pushing the state-of-the-art in classification, detection and segmentation tasks. Over the last years, vision transformers (ViTs) have appeared as a competitive alternative to CNNs, yielding impressive levels of performance in the natural image domain, while possessing several interesting properties that could prove beneficial for medical imaging tasks. In this work, we explore the benefits and drawbacks of transformer-based models for medical image classification. We conduct a series of experiments on several standard 2D medical image benchmark datasets and tasks. Our findings show that, while CNNs perform better if trained from scratch, off-the-shelf vision transformers can perform on par with CNNs when pretrained on ImageNet, both in a supervised and self-supervised setting, rendering them as a viable alternative to CNNs.
Forward citations
Cited by 2 Pith papers
-
Hierarchical Deep Feature Fusion and Ensemble Learning for Enhanced Brain Tumor MRI Classification
A ViT feature ensemble plus ML classifier voting pipeline is evaluated on two binary brain MRI datasets, reporting up to 99.8% accuracy without a same-dataset comparison against prior methods.
-
Advancements in Medical Image Classification through Fine-Tuning Natural Domain Foundation Models
Fine-tuning recent natural-domain foundation models, especially AIMv2, improves medical image classification accuracy across mammography, skin lesion, retinopathy, and chest X-ray benchmarks.
Discussion (0). Sign in to comment.